Literature DB >> 12674498

Hepatitis B virus HBx peptide 116-138 and proteasome activator PA28 compete for binding to the proteasome alpha4/MC6 subunit.

Ralf Stohwasser1, Hermann-Georg Holzhütter, Undine Lehmann, Peter Henklein, Peter M Kloetzel.   

Abstract

PA28 is a modulator of the 20S proteasome. The PA28 binding sites on the 20S proteasome are still not well defined. Using yeast two-hybrid interaction assays and proteasome inactivation kinetics we provide evidence that the proteasome alpha4 subunit is one of the PA28 binding sites. This finding is supported by the observation that a hepatitis B virus X protein-derived polypeptide habouring the alpha4 proteasome subunit binding motif impairs the activation of 20S proteasomes by PA28.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12674498     DOI: 10.1515/BC.2003.005

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  9 in total

1.  Inhibition of cellular proteasome activities mediates HBX-independent hepatitis B virus replication in vivo.

Authors:  Zhensheng Zhang; Eun Sun; Jing-hsiung James Ou; T Jake Liang
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

Review 2.  Ubiquitin-independent proteasomal degradation during oncogenic viral infections.

Authors:  Jiwon Hwang; Laura Winkler; Robert F Kalejta
Journal:  Biochim Biophys Acta       Date:  2011-06-06

3.  Bortezomib inhibits hepatitis B virus replication in transgenic mice.

Authors:  Prasanthi Bandi; Mayra L Garcia; Carmen J Booth; Francis V Chisari; Michael D Robek
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

Review 4.  Proteins directly interacting with mammalian 20S proteasomal subunits and ubiquitin-independent proteasomal degradation.

Authors:  Raúl Sánchez-Lanzas; José G Castaño
Journal:  Biomolecules       Date:  2014-12-19

Review 5.  Hepatitis B virus HBx protein interactions with the ubiquitin proteasome system.

Authors:  Marissa M Minor; Betty L Slagle
Journal:  Viruses       Date:  2014-11-24       Impact factor: 5.048

6.  Proteasome Activators, PA28α and PA28β, Govern Development of Microvascular Injury in Diabetic Nephropathy and Retinopathy.

Authors:  Saeed Yadranji Aghdam; Ali Mahmoudpour
Journal:  Int J Nephrol       Date:  2016-10-18

7.  PA28 modulates antigen processing and viral replication during coxsackievirus B3 infection.

Authors:  Dorota Respondek; Martin Voss; Ina Kühlewindt; Karin Klingel; Elke Krüger; Antje Beling
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

8.  Proteasome activator PA28γ-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.

Authors:  Haiyang Zhang; Jialu Tu; Chulei Cao; Ting Yang; Liangcai Gao
Journal:  Biochem Biophys Res Commun       Date:  2020-06-16       Impact factor: 3.575

Review 9.  Race to arsenal COVID-19 therapeutics: Current alarming status and future directions.

Authors:  Ankit Kumar Dubey; Aakansha Singh; Shardendu Prakash; Manoj Kumar; Ashok K Singh
Journal:  Chem Biol Interact       Date:  2020-10-27       Impact factor: 5.192

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.